and methods for the reliable profiling of minute RNA quantities, which is important for translational research and clinical applications of RNA-seq.
Over the past 10 years we have come to appreciate the dynamic state of genomes, including both DNA modifications and RNA quantitative and qualitative changes, which have been characterized in species ranging from simple model organisms to humans. This advance has occurred through the use of various genomic measurements, including comprehensive transcriptomics studies 1 . We now have a new appreciation for the complexity of the transcriptome, encompassing a multitude of previously unknown coding and non-coding RNA species, particularly small RNAs (sRNAs), including microRNAs, promoter-associated RNAs and newly discovered antisense 3′ termini-associated RNA, to name a few 2, 3 . Initial transcriptomics studies largely relied on hybridization-based microarray technologies and offered a limited ability to fully catalogue and quantify the diverse RNA molecules that are expressed from genomes over wide ranges of levels. The introduction of high-throughput next-generation DNA sequencing (NGS) technologies 4 revolutionized transcriptomics by allowing RNA analysis through cDNA sequencing at massive scale (RNA-seq). This development eliminated several challenges posed by microarray technologies, including the limited dynamic range of detection 5 . NGS platforms used for RNA-seq are commercially available from four companies -Illumina, Roche 454, Helicos BioSciences and Life Technologies -and new technologies are in development by others 4 . Given the importance of sequencing capabilities, such as throughput, read length, error rate and ability to perform paired reads, for RNA-seq as well as genomic studies, NGS companies are constantly improving their platforms to provide the best sequencing performance at the lowest cost 4 . New methodologies for RNA-seq studies have been providing a progressively fuller knowledge of both the quantitative and qualitative aspects of transcript biology in both prokaryotes 6 and eukaryotes 5 . Here we discuss these advances, which have included the development of approaches to allow a more comprehensive understanding of transcription initiation sites, the cataloguing of sense and antisense transcripts, improved detection of alternative splicing events and the detection of gene fusion transcripts, which has become increasingly important in cancer research -all at a data scale that was unimagined just several years ago. Recently developed approaches also allow the selection of specific RNA molecules before RNA-seq, allowing transcriptomics studies with more focused aims. In this Review, we provide an overview of these methods, touching only briefly on the types of biological insight that they allow, and focusing on the technologies themselves. We provide a comparison of the different approaches that are available for each application and discuss the current limitations and the potential for future improvements. We conclude by discussing two new developments in RNA-seq technologies: direct RNA sequencing (DRS)
Semisuppressive PCR
A PCR strategy that aims to reduce primer dimer accumulation by preferentially amplifying longer DNA fragments.
products and to identify adjacent promoter regions that regulate the expression of each transcript. One of the first high-throughput TSS mapping methods was the cap analysis of gene expression (CAGe) approach, which was initially developed for Sanger sequencing 8, 9 . This involved sequencing of cloned cDNA products derived from RNAs with intact 5′ ends (for example, containing a 5′ cap structure). Although useful, the technology required high quantities of input RNA and generated only short reads (~20 nucleotides) per TSS.
These limitations prompted the adaptation of the CAGe approach for NGS platforms, which has resulted in the discovery of the unexpected complexity of TSS distribution across genomes and in the regions surrounding individual promoters. methods that combine RNA-seq with CAGe include deepCAGe 10 , PeAT 11 , nanoCAGe and CAGescan 12 , which collectively resolve several technical challenges of the initial Sanger sequencingbased CAGe strategies (TABLE 1) . first, nanoCAGe 12 now allows TSS mapping from total RNA quantities as small as 10 nanograms through the use of various amplification strategies. Second, the compatibility of PeAT and CAGescan with paired-end sequencing (a capability that is enabled by platforms such as Illumina, but is lacking in others such as Helicos) allows examination of the connectivity of TSSs with downstream regions and facilitates the assignment of identified TSSs to specific transcripts. In addition, paired-end sequencing partly alleviates the difficulty of aligning single short reads to repeat regions and thus allows a subset of repeat elements to be at least partially characterized by RNA-seq.
However, there are several caveats of these NGSbased approaches. One is that no attempt has been made to examine whether the amplification and other manipulation steps that are carried out distort the resulting view of how frequently each TSS is used. Spike-in experiments would be useful to address this issue. In addition, multiple difficulties were encountered during the development of protocols involving cDNA synthesis and amplification 12 . for example, researchers observed artefacts such as primer dimers that dominated sequencing data sets and reduced effective coverage, prompting the use of semisuppressive PCR to reduce primer dimer frequency 12 . Thus, although these methods may be useful for qualitative applications, establishing and improving their quantitative capabilities will probably require additional development.
General limitations of RNA-based TSS mapping approaches include their dependence on cDNA synthesis or hybridization steps, the efficiency of which is dependent on RNA sequence and structure. In addition, RNA-based TSS mapping is challenging for short-lived transcripts such as primary microRNAs, which are transcribed generally at high levels but are scarce owing to their rapid degradation. These limitations may be partly alleviated when combined with other methods such as chromatin-based TSS prediction, which relies on detecting histone modifications that are indicative of active transcription 13, 14 . Such integration may also be useful in light of the recent suggestion that post-transcriptional processing results in 5′ cap-like structures in RNA fragments 15 . Thus, relying solely on CAGe data for TSS mapping may result in difficulties in separating transcription initiation events from RNA processing events.
Strand-specific rNA-seq Transcriptomic studies in a range of species have revealed a pervasive presence of antisense transcription events 16 . Although these events were once considered to reflect biological or technical noise, it is now clear that antisense transcripts are functional and have various roles in both normal physiological states and disease states 16 . There is therefore an increasing interest in profiling transcriptomes at greater depths to fully characterize sense and antisense transcription products. Standard RNA-seq approaches generally require double-stranded cDNA synthesis, which erases RNA strand information. In addition, during first-strand cDNA synthesis, spurious second-strand cDNA artefacts can be introduced, owing to the DNA-dependent DNA polymerase (DDDP) activities of reverse transcriptases [17] [18] [19] , which can confound sense versus antisense transcript determination 20 . Actinomycin D has been suggested as a potential agent to reduce DDDP activities of reverse transcriptases 18 , but the extent to which it is effective, and whether or not it introduces additional artefacts, has not been fully examined. To overcome these difficulties, several strategies for strand-specific analyses of transcriptomes have been developed.
The strategies that have been developed to generate strand-specific information generally rely on one of three approaches. The first involves the ligation of adaptors in a predetermined orientation to the ends of RNAs or to first-strand cDNA molecules [21] [22] [23] . The known orientations of these adaptors are used as reference points to obtain RNA strand information. A second approach is the direct sequencing of the first-strand cDNA products that are generated, either in solution 24, 25 or on surfaces 26 . Last, a third approach is the selective chemical marking of the second-strand cDNA synthesis products or RNA 27, 28 . These strategies have already begun to contribute to our understanding of transcriptomes, including mapping of translation states of RNAs (for example, polysome profiling) 29 and identification of novel promoter-associated RNAs 22 . A recent study that used the Saccharomyces cerevisiae genome as a reference compared the performance of several of these strategies, and the authors observed differences in these methods with respect to their level of strand specificity, evenness of coverage, agreement with known annotations, library complexity (for example, number of unique read start positions, which indicates the protocols' abilities to avoid amplification artefacts such as duplicate reads) and ability to generate quantitative expression profiles 30 . However, in-depth comparative studies that characterize the biases and artefacts that are introduced by each of these approaches are still lacking, and scientists working with these data sets should be aware of several issues.
first, given the tendency of reverse transcriptase to generate spurious second-strand cDNA products during first-strand cDNA synthesis [17] [18] [19] , it is not clear whether the approaches that rely on sequencing first-strand cDNA products (either directly or by intra-or intermolecular ligation) are absolutely strand specific. The strand specificity of such approaches has been reported by quantifying the ratio of reads that map in the antisense orientation to the known, well-annotated genes, relative to the reads that map in the sense orientation. This investigation revealed that a small fraction of reads obtained with these approaches still align in the antisense orientation; thus, these approaches may not be entirely strand-specific 30 . furthermore, cDNA products that contain both first-and second-strand cDNA products may not align properly to reference sequences. Given the incomplete annotations of sense and antisense transcripts in genomes, even in those of well-studied species such as S. cerevisiae, the true extent of strand specificity of these approaches should be carefully assessed. Ideally, such assessment should be performed with chemically synthesized RNA spike pools of defined sequence.
Second, ligation tends to have sequence preferences 31, 32 . Thus, the approaches that rely on ligation may suffer from various representational biases. examples of such bias are found in transcriptome profiling 23 and ribosome profiling experiments 29 , in which extremely uneven coverage was seen for libraries prepared using ligation, compared with libraries prepared using enzymatic 3′ polyadenylation 29 . Third, the in-solution or on-surface amplification step included in some of these approaches may introduce additional artefacts -for example, in the form of GC biases and duplicate reads [33] [34] [35] . examination of such effects revealed a duplicate read fraction in the range of 6.1% to 94.1% for standard and strand-specific Illumina RNA-seq strategies, and the existence of GC bias towards RNA templates with neutral GC content 23 . It is hoped that many of these limitations will be overcome by the sequencing technologies that are in development or with modifications and improvements to existing sequencing technologies 4 .
Characterization of alternative splicing patterns Given the importance of alternative splicing patterns in development and the fact that 15-60% of known diseasecausing mutations affect splicing 36, 37 , it will be crucial to catalogue the complete repertoire of splicing events and to understand how altered splicing patterns contribute to development, cell differentiation and human disease. Initial splice-site mapping studies using RNA sequencingbased approaches were limited by read length, which prevented the reliable alignment to the genome of the two independent exonic portions of each read, representing the exon splicing event. Thus, initial RNA-seqbased studies of alternative splicing used computational strategies to compensate for this limitation. The reference sequence used for alignment was supplemented with 'artificial' sequences that surround all possible splice junctions between the annotated exons of genes, allowing the reads to be aligned [38] [39] [40] [41] . These approaches changed our view of human splicing, as more than 95% of human multi-exon genes were found to be alternatively spliced, with ~110,000 novel splice sites per tissue 42 . By counting the number of reads mapping to each exon and spanning each splice junction, these approaches also allowed the splice efficiency of each junction to be determined and the levels of distinct isoforms to be quantified 43, 44 . Improvements to current sequencing technologies now enable longer read lengths, allowing better mapping of the reads to the alternatively spliced exons. This improvement comes from being able to partition the reads into multiple pieces and to align each piece independently to the genomes. In addition, approaches that involve paired-end reads now enable sequence information to be obtained from two points in a transcript with an estimated distance between the reads. As a result, it is now possible to search for splicing patterns without a requirement for prior knowledge of transcript annotations 45, 46 (FIG. 1) . examination of splicing patterns and transcript connectivity in an unbiased and genomewide manner requires full-length transcript sequences to be obtained, which may be enabled in the future by emerging technologies 47, 48 .
Gene fusion detection RNA-seq combined with computational analyses analogous to the ones described above for splice-site detection can also be used to identify gene fusion events in disease tissues, which has particular importance for cancer research 49 . Genomic DNA can be analysed with singleread and paired-end-read strategies for the detection of translocations and other genomic rearrangements 50 . However, RNA-seq may be preferable for identifying events that produce aberrant RNA species and therefore have a higher likelihood of being functional or causal in biological or disease settings 51, 52 (FIG. 2) .
furthermore, genomic DNA-based approaches cannot identify fusion events that are due to non-genomic factors, such as trans-splicing 53 and read-through events between adjacent transcripts 51, 54 . Paired-end RNA-seq can be particularly advantageous for fusion identification because of the increased physical coverage it offers. This approach has led to important biological findings in oncology 55, 56 , offering potential targets for therapeutic modulation.
The challenges faced in fusion detection are generally in parallel with those for alternative splicing detection. In addition, RNA-seq-based analyses cannot detect fusion events that involve the exchange of the promoter of a gene with the coding sequence of another gene. furthermore, RNA-seq data include chimeric cDNA artefacts that are generated by template switching during reverse transcription and amplification 57 (discussed below), leading to false positives in gene fusion identification. These difficulties may be partly alleviated when long-read RNA sequencing technologies with sufficient throughput and sequencing performance become available 4 .
Targeted approaches using rNA-seq Despite the increasing capabilities of NGS in terms of throughput and decreasing costs per data point, the expenditure necessary to obtain sufficient sequencing coverage for several research and potential clinical applications is still prohibitive. Such applications include the characterization of low-abundance transcripts and genotyping to determine, for example, which alleles of the transcripts might be differentially expressed. In these scenarios, it may be preferable to enrich for the desired subset of transcripts, to minimize the overall cost of sequencing and maximize the number of samples that can be analysed.
Target-enrichment strategies were originally developed for genomic DNA resequencing 4, 58 . many of these technologies have been used to capture the human exome from genomic DNA, given that a large fraction of disease-causing mutations are likely to be located in the protein-coding transcriptome. RNA-seq of poly(A) + RNA species offers a natural route for exome sequencing without the use of enrichment strategies. The potential suitability of mRNA-seq data for the identification of nucleotide variations has been demonstrated recently by several studies [59] [60] [61] . However, these studies also underscored some challenges -for example, the high sequencing depth required to sufficiently cover low-abundance transcripts.
Slight modifications of the genomic DNA-enrichment strategies for cDNA applications have allowed the development of targeted RNA-seq (FIG. 3) . Targeted RNA-seq approaches have been used to detect fusion transcripts, allele-specific expression, mutations and RNA-editing events in a subset of transcripts [62] [63] [64] . Targeted RNA-seq strategies currently require longer sample preparation steps and higher input RNA and cDNA quantities than do other RNA-seq approaches, owing to the additional probe or microarray preparation and target-selection steps. furthermore, capture efficiency usually differs between target regions depending on hybridization efficiency and other factors. Simplification of this process and improvements in capture efficiency are desirable for better experimental outcomes.
Small rNA profiling
The impact of NGS technologies on sRNA discovery and characterization has been particularly noteworthy. These studies have been reviewed extensively by others (for example, see REF. 65 ), so we do not review this topic in depth here but provide a brief summary for completeness. most initial sRNA-discovery studies used pyrosequencing 66, 67 . Subsequently, the use of other NGS platforms with higher throughput has resulted in genome-wide surveys and the discovery of an evergrowing number of sRNA species 15, 68, 69 . Because NGS sample preparation strategies for 'longer' RNAs (>200 nucleotides) are not suitable for sRNAs, such as reverse transcription with random priming (because this way of priming cDNA synthesis from short RNA species yields even shorter cDNA species that are not long enough for efficient alignment), modified preparation strategies were developed [70] [71] [72] . One important limitation of the current RNA-seqbased approaches for studying sRNAs is their inability to provide an absolutely quantitative view of these transcripts. It has recently become clear that, although the NGS-based sRNA-profiling approaches can be used for differential expression analyses, the number of reads obtained per sRNA does not necessarily correlate with their actual abundance 73, 74 . This discrepancy seems to be due to biases that are introduced during the sample preparation and sequencing steps. Whether emerging technologies can improve sRNA quantification remains to be seen.
Direct rNA sequencing cDNA synthesis and other RNA manipulations limit some RNA-seq applications. As noted above, most current RNA-seq methods rely on cDNA synthesis and a range of subsequent manipulation steps, which places limitations on the current approaches for some applications. for example, as we have discussed, the generation of spurious second-strand cDNAs can present difficulties for strand-specific RNA-seq. Strand-specific libraries can also be prepared to avoid this problem (discussed above), but the approaches that use RNA-RNA ligation are laborious to construct. Another limitation imposed by cDNA synthesis is template switching [75] [76] [77] . During the process of reverse transcription, the nascent cDNA that is being synthesized can sometimes dissociate from the template RNA and re-anneal to a different stretch of RNA with a sequence similar to the initial template, generating artefactual chimeric cDNAs. Template switching may cause problems in the identification of exon-intron boundaries and true chimeric transcripts. Reverse transcriptases can also synthesize cDNA in a primer-independent manner, which is thought to be caused by self priming arising from the RNA secondary structure. This results in the generation of random cDNA synthesis. furthermore, reverse transcriptases have lower fidelity compared to other polymerases owing to their lack of proofreading mechanisms 78, 79 , and they have variable RNA to cDNA conversion efficiency depending on the experimental conditions.
In addition to their requirement for cDNA synthesis, current RNA-seq approaches can present other difficulties. first, the RNA-seq signal across transcripts tends to show non-uniformity of coverage, which may be a result of biases introduced during various steps, such as priming with random hexamers 80, 81 , cDNA synthesis, ligation 31, 32 , amplification 35 and sequencing [33] [34] [35] 82 . Second, commonly used RNA-seq strategies can result in transcript-length bias because of the multiple fragmentation and RNA or cDNA size-selection steps they use 83 . This bias may result in complications for downstream analyses 84 . Third, quantification of transcripts with RNA-seq requires consideration of read mapping uncertainty (owing to sequencing error rates, repetitive elements, incomplete genome sequence and inaccuracies in transcript annotations) 85 and normalization of the number of reads mapping to each transcript, based on transcript length. Despite improvements in sequencing methods and bioinformatics advances allowing de novo construction of transcriptomes 86, 87 , the existing approaches are often not sufficient to detect certain transcripts and/or cover their entire length. Together with the uncertainty regarding transcript boundaries and length because of events such as alternative splicing, polyadenylation sites and promoter usage, the required lengthnormalization step is a potential source of errors for quantitative applications. fourth, RNA-seq strategies often involve a poly(A) + mRNA-enrichment step. Polyadenylation of transcripts also takes place during transcript degradation steps, and thus poly(A) + -enrichment steps may also enrich for RNA degradation products of RNA polymerase I transcripts and other RNAs 88 .
Direct sequencing of RNAs. The limitations of current RNA-seq approaches discussed above might be at least partly alleviated by emerging RNA analysis technologies, including DRS, that substantially alter the method of RNA characterization. DRS currently requires single-molecule sequencing capabilities, as the amplification of RNA molecules directly without cDNA conversion has not been examined. Although RNAdependent RNA polymerases do exist 89 , the extent to which they can be adapted to the amplificationbased next-generation sequencing technologies is unknown at present.
The first massively parallel DRS approach was recently developed using the Helicos single-molecule sequencing platform 7, 90, 91 (FIG. 4) . It relies on hybridization of several femtomoles of 3′-polyadenylated RNA templates to single channels of poly(dT)-coated sequencing surfaces, followed by sequencing by synthesis. This approach can select and sequence poly(A) + RNA from total RNA or cellular lysates, with sequence data being derived from regions immediately upstream of the polyadenylation sites 7 . Thus, the technology offers a path to obtain gene expression profiles and map polyadenylation sites in a quantitative and genome-wide manner. RNA species that lack natural poly(A) tails can be polyadenylated in vitro and analysed with DRS.
The development of DRS approaches that are free from cDNA synthesis artefacts such as template switching and spurious second-strand synthesis provides potential improvements for applications such as the surveying of strand-specific transcription. furthermore, DRS requires only femtomole or attomole levels of input RNA, depending on the application, and involves relatively simple sample preparation. DRS-type technologies may therefore be advantageous for applications that are challenging for current cDNAbased methodologies, such as experiments that yield subnanogram-level RNA (discussed below), archival specimens or short RNA species, which cannot be easily converted to cDNA. furthermore, unlike cDNA-based approaches, which require different strategies for the analysis of short and longer RNA species, DRS sample preparation involving polyadenylation can be applied to any RNA species, thus allowing both short and long RNAs to be observed in a single experiment. DRS may in the future also simplify targeted RNA-seq by enabling the integration of target selection and sequencing steps (FIG. 3d) . Such integration may reduce the sample preparation steps to only nucleic acid fragmentation, and may minimize costs as well as the quantity of input nucleic acid required.
A key challenge for DRS is to generate the multimillion-level read quantities that are required for many RNA applications, particularly quantification, and to further reduce error rates and input RNA quantities through alterations to the sequencing chemistry and template-capture steps. DRS may also not solve all of the RNA-seq limitations listed above -including, for example, the issues of degradation products being captured during poly(A) + RNA selection. furthermore, the combination of paired-end approaches with DRS and longer read lengths is needed for various applications discussed above, including studies focusing on the identification of 5′ (for example, CAGe-type TSS mapping) and 3′ boundaries of RNA species. + RNA converted to double-stranded cDNA the Agilent SureSelect method uses RNA probes to enrich selected cDNA 62 . b | A custom NimbleGen array may allow selection of cDNAs of interest. c | The generation of DNA molecules with sequence-specific complementary targeting sites allows the targeting of cDNAs 63, 64 . d | Helicos sequencing surfaces containing target-specific oligonucleotides can be used to select desired RNA, DNA and cDNA species and sequence regions of interest in a single step. nt, nucleotide.
Laser capture microdissection
(Often abbreviated to LCM.) A method allowing cells of interest that are chosen by the operator using a microscope to be specifically captured from heterogeneous tissue samples. The isolated cells can be used for various analyses including of protein and nucleic acid.
Profiling low-quantity rNA samples Biological specimens (such as tissue and body fluids) are generally heterogeneous, being a complex mixture of multiple cell types. The need to specifically select and study particular cells is clear, but the implementation of this task is not straightforward. Several tools now allow selection of specific cell types, such as flowassisted cell sorting (fACS), laser-capture microdissection (LCm) 92 , serial dilution, specialized microfluidic devices 93 and micromanipulation. In addition, methods for high-quality RNA isolation from small quantities of cells are also available. The main limitation preventing reliable, global profiling of minute RNA quantities has been the incompatibility of high-throughput RNA profiling approaches with low-quantity RNA samples. The absence of such methods has slowed our progress in a range of areas, such as forensics, stem cell biology, metagenomics and plant biology. The effects of this limitation are perhaps most acutely felt in research into cancer and other diseases, as samples obtained from patients are generally limited in quantity; the transition between findings from molecular profiling studies and technologies for use in clinical research and molecular diagnostics is being held back, slowing our progress towards personalized medicine. Strategies that can provide a comprehensive and bias-free view of transcriptomes using picogram quantities of input RNA would therefore stimulate great advances in a range of areas.
Methods for small quantities of RNA. The analysis of low-quantity RNA samples with global microarray and sequencing technologies has traditionally required one or more amplification step(s) to obtain sufficient nucleic acid material for subsequent detection. Since the early 1990s, several nucleic acid amplification strategies for low-quantity RNA applications have been developed, such as ligation-mediated PCR 94 , multiple displacement amplification (mDA) 95 , single-primer isothermal amplification 96 and in vitro transcription (IvT)-based linear amplification 97 . The ideal amplification method should provide accurate sequences with a low or zero error rate, be reproducible, produce high levels of amplification to provide the quantities of nucleic acid needed, be applicable for nucleic acids from a wide array of species, and preserve the representation of the distinct RNA molecules in the original sample. To what extent the current methods meet these criteria is not clear. Studies performed with microarraybased measurements suggest that amplification introduces variability and discrepancies, especially for middle-and low-abundance transcripts and as input RNA quantity is lowered further 98 . Sequencing-based low-quantity RNA profiling is relatively new. A recently reported mRNA-seq method relies on double PCR amplification steps and can be used to profile the transcriptomes of single oocytes 40 . It was observed, however, that the reproducibility of such low-quantity RNA-seq approaches may be negatively affected owing to stochastic amplification biases that may result in the drop-out of some RNA species and preferential amplification of others 23 . Such outcomes can lead to, for instance, duplicate reads and reduced quantification power.
Emerging technologies. A number of both hybridization-and sequencing-based technologies are now emerging that may allow reliable transcriptome profiles to be obtained from minute cell quantities. On the sequencing side, nanoCAGe 12 now allows TSS mapping from 10 nanograms of total RNA through the use of various amplification strategies. Amplification-free RNA-seq approaches have recently been developed that minimize the quantity of input RNA required. One approach involves the sequencing of first-strand cDNA products from as little as ~500 picograms of RNA, with priming carried out in solution with oligo-dT or random hexamers 24, 25 . Another approach involves the use of poly(dT) primers on sequencing surfaces to select for poly(A) + mRNA from cellular lysates, followed by onsurface first-strand cDNA synthesis and sequencing 26 . This approach allows reproducible gene expression profiles to be obtained from ~1,000 cells and eliminates RNA loss during the RNA isolation steps, which may be particularly important as the input cell quantity is reduced. As described above, DRS eliminates the cDNA synthesis stage and requires only a few femtomoles of RNAs containing natural poly(A) tails or RNAs polyadenylated in vitro. It is also conceivable that microfluidic capabilities could be combined with DRS for single-cell applications (FIG. 5a) .
Hybridization-based methodologies are also providing promise for working with very small quantities of RNA. The NanoString nCounter System provides an alternative method for RNA quantification without the requirement for cDNA synthesis, and it relies on the generation of target-specific probes (FIG. 5b) . The probe mixture is hybridized to RNA samples in solution, followed by the immobilization of probe-RNA duplexes on surfaces and single-molecule imaging to identify and count individual transcripts 99 . In principle, the system can detect up to 16,384 transcripts simultaneously. This approach requires ~100 nanograms of RNA or 2000-5,000 cells 100 , but optimization of the probe hybridization and surface immobilization steps may further reduce input RNA quantity. Figure 4 | Direct RnA sequencing using the Helicos approach. a | RNA that is polyadenylated and 3′ deoxy-blocked with poly(A) polymerase is captured on poly(dT)-coated surfaces. A 'fill-and-lock' step is performed, in which the 'fill' step is performed with natural thymidine and polymerase, and the 'lock' step is performed with fluorescently labelled A, C and G Virtual Terminator (VT) nucleotides 104 and polymerase. This step corrects for any misalignments that may be present in poly(A) and poly(T) duplexes, and ensures that the sequencing starts in the RNA template rather than the polyadenylated tail. b | Imaging is performed to locate the positions of the templates. Then, chemical cleavage of the dye-nucleotide linker is performed to release the dye and prepare the templates for nucleotide incorporation. c | Incubation of this surface with one labelled nucleotide (C-VT is shown as an example) and a polymerase mixture is carried out. After this step, imaging is performed to locate the templates that have incorporated the nucleotide. Chemical cleavage of the dye allows the surface and DNA templates to be ready for the next nucleotide-addition cycle. Nucleotides are added in the C, T, A, G order for 120 total cycles (30 additions of each nucleotide).
◀ Quantitative real-time polymerase chain reaction
A PCR application that enables the measurement of nucleic acid quantities in samples. Nucleic acid of interest is amplified with PCR. The level of the amplified product accumulation during PCR cycles are measured in real time. This data is used to infer starting nucleic acid quantities.
Circulating extracellular nucleic acid
Extracellular DNA or RNA molecules in plasma and serum.
fluidigm offers a microfluidics platform that can perform quantitative real-time polymerase chain reaction (qRT-PCR) experiments on gene panels in a multiplexed manner and has been used to profile single cells. Commercial kits allowing one-step cDNA synthesis and amplification are used for cell lysis, cDNA synthesis and PCR amplification of the transcript region of interest. Pre-amplified cDNAs are then introduced to the fluidigm Dynamic Array for qRT-PCR analysis. This approach may be useful for the determination of the expression levels of a subset of transcripts across cells of interest 101, 102 . None of the approaches described above is mature, and none so far fully addresses our need for reliable, genome-wide and in-depth transcriptome profiles from minute cell quantities. for example, both the fluidigm and NanoString technologies interrogate only a selected subset of transcripts and do not provide comprehensive analyses. However, it is hoped that future advances that will arise from the foundation formed by these technologies will enable such capabilities.
Future perspectives
Recent advances in RNA-seq have provided researchers with a powerful toolbox for the characterization and quantification of the transcriptome. emerging sequencing technologies promise to at least partly alleviate the difficulties of current RNA-seq methods and equip scientists with better tools. using these technological advances, we can build a complete catalogue of transcripts that are derived from genomes ranging from those of simple unicellular organisms to complex mammalian cells, as well as in tissues in normal and disease states. furthermore, with our increasing ability to work with minute RNA quantities from fresh and formalin-fixed paraffin-embedded tissues and cells, and to provide quantification of RNA species from even single cells, we have the opportunity to define complex biological networks in a wide range of biological specimens. With these networks in hand, we can use data-driven RNA network models of cells and tissues in an attempt to fully understand the biological pathways that are active in various physiological conditions. In addition, these technologies are bringing us closer to the ability to use RNA measurements for clinical diagnostics. for example, analysis of circulating extracellular nucleic acid 103 and cells, such as fetal RNA and circulating tumour cells, with these new technologies may allow for earlier assessment of health, disease recurrence or mutational status. Thus, these technologies will continue to help us realize the full potential of genomic information as it relates to basic biological questions of differentiation and diversity, as well as its growing impact on the personalization of healthcare. a | Single-molecule DNA and RNA sequencing technologies could be modified for single-cell applications. Cells can be delivered to flow cells using fluidics systems, followed by cell lysis and capture of mRNA species on the poly(dT)-coated sequencing surfaces by hybridization. Standard sequencing runs could take place on channels with a 127.5 mm 2 surface area, requiring 2,750 images to be taken per cycle to image the entire channel area. The surface area needed to accommodate ~350,000 mRNA molecules contained in a single cell is ~0.4 mm 2 ; thus, only eight images per cycle would be needed. Sequence analysis can be done with direct RNA sequencing (DRS) 7 or on-surface cDNA synthesis followed by single-molecule DNA sequencing 26 . b | Counter system workflow. Two probes are used for each target site: the capture probe (shown in red) contains a target-specific sequence and a modification that allows the immobilization of the molecules on a surface; the reporter probe contains a different target-specific sequence (shown in blue) and a fluorescent barcode (shown by a green circle) that is unique to each target being examined. After hybridization of the capture and reporter probe mixture to RNA samples in solution, excess probes are removed. The hybridized RNA duplexes are then immobilized on a surface and imaged to identify and count each transcript with the unique fluorescent signals on the capture and reporter probes.
